Bachem Holding AG | Cash Flow

Fiscal year is January-December. All values CHF Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
23,604.00
29,065.00
31,838.00
41,205.00
41,770.00
46,644
Depreciation, Depletion & Amortization
18,242.00
19,224.00
18,345.00
19,726.00
20,931.00
23,065
Other Funds
102.00
2,157.00
1,666.00
385.00
641.00
1,161
Funds from Operations
41,744.00
46,132.00
51,849.00
59,459.00
65,610.00
72,962
Changes in Working Capital
7,082.00
753.00
9,468.00
19,237.00
30,049.00
47,522
Net Operating Cash Flow
48,826.00
46,885.00
61,317.00
40,222.00
35,561.00
25,440
Capital Expenditures
12,202.00
15,774.00
25,380.00
51,261.00
50,429.00
Sale of Fixed Assets & Businesses
315.00
4,021.00
41.00
60.00
5,178.00
Net Investing Cash Flow
11,934.00
10,083.00
36,170.00
51,343.00
45,368.00
Cash Dividends Paid - Total
20,253.00
23,651.00
17,069.00
20,484.00
23,946.00
Issuance/Reduction of Debt, Net
5,709.00
23,725.00
14,209.00
27,840.00
-
Net Financing Cash Flow
25,962.00
46,978.00
31,205.00
7,417.00
7,927.00
Net Change in Cash
10,787.00
9,227.00
6,245.00
4,043.00
1,923.00
Free Cash Flow
39,180.00
33,079.00
39,850.00
8,946.00
9,557.00
Deferred Taxes & Investment Tax Credit
-
-
-
1,087.00
2,268.00
2,092
Net Assets from Acquisitions
-
-
10,693.00
-
-
Other Sources
12.00
1,732.00
-
-
17.00
Change in Capital Stock
-
398.00
73.00
61.00
2,414.00
Exchange Rate Effect
143.00
949.00
187.00
339.00
43.00
Other Uses
59.00
62.00
138.00
142.00
134.00

About Bachem Holding

View Profile
Address
Hauptstrasse 144
Bubendorf Basel-Landschaft (Basle Country) 4416
Switzerland
Employees -
Website http://www.bachem.com
Updated 07/08/2019
Bachem Holding AG is a technology-based biochemical company providing full-service to the pharmaceutical and biotechnology industry. The firm operates through the Europe and North America segments. It specializes in the development of manufacturing processes and the production of peptide-based active pharmaceutical ingredients.